Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy

J Park, S Thomas, PN Munster - Epigenomics, 2015 - Taylor & Francis
Understanding the contribution of dysregulated gene silencing to epigenomic alterations in
cancer development provides the rationale for the use of epigenetic modulators, such as …
被引用次数：57 相关文章

Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy

J Park, S Thomas, PN Munster - Epigenomics, 2015 - pubmed.ncbi.nlm.nih.gov
Understanding the contribution of dysregulated gene silencing to epigenomic alterations in
cancer development provides the rationale for the use of epigenetic modulators, such as …

Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy

J Park, T Scott, PN Munster - Epigenomics, 2015 - search.proquest.com
Understanding the contribution of dysregulated gene silencing to epigenomic alterations in
cancer development provides the rationale for the use of epigenetic modulators, such as …

Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.

J Park, S Thomas, PN Munster - Epigenomics, 2015 - europepmc.org
Understanding the contribution of dysregulated gene silencing to epigenomic alterations in
cancer development provides the rationale for the use of epigenetic modulators, such as …

Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.

J Park, S Thomas, PN Munster - Epigenomics, 2015 - go.gale.com
Understanding the contribution of dysregulated gene silencing to epigenomic alterations in
cancer development provides the rationale for the use of epigenetic modulators, such as …